Animal Model Market Trends, Drivers, and Regional Analysis 2025–2029

Uncover key drivers, emerging technologies, and competitive movements shaping the animal model market from 2025–2034 with trusted insights from The Business Research Company

How Is The Animal Model Market Size Expected To Expand Over 2029-2034?

The animal model market has experienced robust expansion over the past few years. Projections indicate it will expand from $1.92 billion in 2024 to reach $2.07 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 8.0%. This historical growth is a result of several factors, including the increased use of animal models in biomedical research, significant spending and substantial capital input in drug development and discovery, an increasing emphasis on precision medicine, and the broad utility of animal models within the healthcare sector.

The animal model market size is poised for significant growth in the coming years, with expectations to reach $2.8 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.9%. This expansion during the forecast period is primarily driven by advancements in genetic engineering, a greater emphasis on personalized medicine, the increasing prevalence of chronic diseases, the growing demand for effective vaccines and therapeutics, and heightened investment in biomedical research. Prominent trends throughout this period encompass a surging demand for animal models in the processes of drug discovery and development, the continued rise in chronic disease prevalence, the benefit of physiological similarities between humans and animals in reducing drug development timelines, the increasing consumption of personalized medicine which drives the need for humanized mice models, and the market’s robust growth fueled by the increasing adoption of animal models for biomedical research.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

Which Market Factors Are Fueling The Animal Model Industry Growth?

The future expansion of the animal model market is anticipated, propelled by the growing investment in pharmaceutical research and development activities. Pharmaceutical R&D represents a complex area where scientific advancements merge with innovation to generate medical breakthroughs. The drive towards new therapies, the search for treatments for intricate diseases, along with inherent scientific curiosity and commercial opportunities within the healthcare sector, all contribute to advancing the research and development process. Animal models play a vital role in pharmaceutical R&D by enabling the prediction of drug efficacy, safety, and toxicity. They also provide crucial insights into biological mechanisms and assist in developing new treatments by emulating human physiological responses and disease progression in controlled settings. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association and lobbying organization, indicated that spending on pharmaceutical research and development across Europe amounted to €44,500 ($47,999) in 2022 and €42,533 million ($45,877 million) in 2021. This demonstrates how the increasing investment in pharmaceutical research and development is driving the animal model market.

Which Categories Are Covered In The Animal Model Market Segmentation Analysis?

The animal model market covered in this report is segmented –

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies

3) By Application: Drug Discovery And Development, Basic Research, Other Applications

4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice

2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats

3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs

4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds

5) By Hamsters: Syrian Hamsters, Chinese Hamsters

6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

Which Market Trends Are Expected To Define The Future Of The Animal Model Market?

Leading companies in the animal model market are concentrating on creating innovative products, such as triple-immunodeficient animal models, with the aim of improving the accuracy and reliability of preclinical studies, supporting advanced biomedical research, and assisting in the development of new therapies for complex human diseases. Triple-immunodeficient animal models are specifically engineered animals, typically mice, that lack three vital components of the immune system. These models are indispensable in biomedical research, particularly for investigating human diseases and developing novel treatments. As an illustration, in January 2024, Charles River Laboratories International, Inc., a US-based pharmaceutical company, introduced NCG mouse strains, which are triple-immunodeficient mouse models designed for oncology research. NCG mice are triple immunodeficient, characterized by the absence of functional/mature T, B, and NK cells, and display reduced macrophage and dendritic cell function. These animal models are capable of hosting xenograft cells, tissues, and human immune system components. This mouse model is exceptionally suited for research in areas such as oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. Furthermore, NCG mice can be utilized to create humanized mice by engrafting PBMCs or CD34+ stem cells, thereby closely mimicking the human immune system.

Which Organizations Are At The Forefront Of The Animal Model Market?

Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd., Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd., Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Animal Model Market?

North America was the largest region in the animal model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp

Browse Through More Reports Similar to the Global Animal Model Market 2025, By The Business Research Company

Animal Produce Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-produce-global-market-report

Animal Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Animal Intestinal Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-intestinal-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795